Table 2 Comparison of HPV gene expression between stages, types of lung cancer, and controls
Cancer characteristic | E2 | E6 | E7 | |
|---|---|---|---|---|
Controls (n = 48) | – | 5.82 ± 2.48 (1) | 8.36 ± 3.14 (1) | 8.64 ± 4.30 (1) |
Stages of Cancer (n = 102) | IA | 4.0 ± 1.27 (0.68) | 9.0 ± 1.2 (1.07) | 8.0 ± 1.89 (0.92) |
IB | 5 ± 1.0 (0.86) | 3.0 ± 1.75 (0.36) | 5.0 ± 0.57 (0.58) | |
IIA | 8 ± 5.29 (1.37) | 8 ± 2.45 (0.95) | 9.75 ± 4.50 (1.13) | |
IIB | 6.83 ± 2.32 (1.17) | 9.1 ± 4.77 (1.09) | 10.8 ± 6.59 (1.25) | |
IIIA | 4.3 ± 3.02 (0.74) | 8.54 ± 3.75 (1.02) | 11.23 ± 4.95 (1.30) | |
IIIB | 6.58 ± 4.08 (1.13) | 8.13 ± 5.23 (0.97) | 10.13 ± 5.17 (1.17) | |
IV | 6.0 ± 3.83 (1.03) | 12.33 ± 4.66 (1.47) | 13.56 ± 5.13 (1.57) | |
P-value | 0.585 | 0.301 | 0.643 | |
Types of Cancer (n = 102) | Adenocarcinoma | 5.83 ± 3.69 (1) | 9.67 ± 4.99 (1.17) | 11.94 ± 4.93 (1.38) |
Squamous-cell carcinoma | 6.39 ± 3.69 (1.1) | 8.63 ± 4.70 (1.03) | 10.17 ± 5.57 (1.18) | |
Small-cell lung carcinoma | 3.67 ± 1.15 (0.63) | 9.0 ± 3.28 (1.07) | 11.67 ± 5.09 (1.35) | |
P-value | 0.466 | 0.762 | 0.504 | |